Probiotics supplement for the prevention of eczema in children: Study protocol for a meta-analysis and systematic review

Wenhao Yang, Renyuan Tu, Yanan Hu, Tao He, Weijian Zhang, Li Gu, Hanmin Liu, Wenhao Yang, Renyuan Tu, Yanan Hu, Tao He, Weijian Zhang, Li Gu, Hanmin Liu

Abstract

Background: Atopic dermatitis (AD), also called eczema, is one of the most familiar chronic diseases in childhood. A possible pathological mechanism is immune dysfunction resulting in IgE sensitization to allergens. The recent studies demonstrated that the immune system can be affected by probiotics or prebiotics. However, the effectiveness and safety of probiotics or prebiotics on prevention of eczema are still unclear. To investigate this question, we conduct a systematic review and meta-analysis.

Methods: The protocol followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. Four main databases (PubMed, Embase, the Cochrane Library, and the web of science) will be searched dating until 15 July 2019 for randomized controlled trials investigating the effects and safety of probiotics or prebiotics on prevention of eczema in children with no language restrictions. In addition, a manual search of the references of relevant published studies will also be considered.Studies selection, data extraction, and risk of bias assessment will be conducted by two independent reviewers. The primary outcome is the incidence of eczema. The second outcome is adverse events. The duration of intervention, the timing of intervention and intervention organism will be taken into consideration.

Results: The results will provide useful information about the effect and safety of probiotics or prebiotics on reducing the incidence of eczema in children.

Conclusion: The findings of this study will be published in a peer-reviewed journal.PROSPERO registration number: CRD42019136528.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram of study selection.

References

    1. Chamlin SL, Frieden IJ, Williams ML, et al. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004;114:607–11.
    1. Shaw TE, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011;131:67–73.
    1. Drucker AM, Wang AR, Li WQ, et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 2017;137:26–30.
    1. Dissanayake E, Tani Y, Sahara M, et al. Skincare and synbiotics for the prevention of atopic dermatitis or food allergy in newborn infants: a 2 × 2 factorial randomized non-treatment controlled trial. Allergy: Eur J Allergy Clin Immunol 2018;73:692–3.
    1. Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England) 2016;387:1109–22.
    1. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232–6.
    1. Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14:491–502.
    1. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016;16:341–52.
    1. Ou Y, Chen S, Ren F, et al. Lactobacillus casei strain shirota alleviates constipation in adults by increasing the pipecolinic acid level in the gut. Front Microbiol 2019;10:324.
    1. Gopalakrishnan V, Helmink BA, Spencer CN, et al. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer cell 2018;33:570–80.
    1. Fiocchi A, Pawankar R, Cuello-Garcia C, et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J 2015;8:4.
    1. Yan D-C, Hung C-H, Sy LB, et al. A randomized, double-blind, placebo-controlled trial assessing the oral administration of a heat-treated Lactobacillus paracasei supplement in infants with atopic sermatitis receiving topical corticosteroid therapy. Skin Pharmacol Physiol 2019;32:201–11.
    1. Yin D-G, He Z, Duan X-Y, et al. Effect of probiotic supplementation during pregnancy and infancy in preventing atopic dermatitis in children: a meta analysis. Zhongguo dang dai er ke za zhi = Chin J Contemp Pediatrics 2019;21:82–8.
    1. Schmidt RM, Pilmann Laursen R, Bruun S, et al. Probiotics in late infancy reduce the incidence of eczema: a randomized controlled trial. Pediatric Allergy Immunol 2019;30:335–40.
    1. Higgins JPT GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration; 2011.
    1. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from .

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi